Weill Family Foundation

The Weill Family Foundation is among the most concentrated, relationship-driven philanthropies in American medical research — and the most important thing to understand is that it does not accept unsolicited applications. Founded and fully controlled by Sanford "Sandy" Weill (Chairman, former Citigroup CEO) and Joan Weill (President), the foundation operates as a family-directed vehicle with all board seats held by Weill family members and their closest advisors: daughter Jessica Bibliowicz, son Marc Weill, Secretary Michael Masin, and Chief Investment Officer Michael Freedman. There are no open competitions, no grants portal, and no published eligibility criteria.

The dominant giving model is transformational hub-building: the Weills identify a frontier research problem, select a lead anchor institution, negotiate a named multi-decade partnership, and fund it with a $50M–$185M pledge paid over multiple years. This produced the UCSF Weill Institute for Neurosciences ($185M, 2016), the Weill Neurohub connecting UCSF, UC Berkeley, and UW ($106M, 2019), and the Weill Cancer Hubs East and West ($150M+ combined, 2025). Individual investigators, small nonprofits, and organizations without existing institutional relationships with the Weills have no realistic direct pathway.

The secondary giving tier involves sustained modest support to arts, cultural, and human services organizations the Weills personally champion — Carnegie Hall ($3M), Alvin Ailey Dance Foundation ($250K), Hebrew Home for the Aged ($1M), and Citymeals on Wheels ($480K). These relationships are entirely Board-to-Board or personally solicited; they cannot be cold-pitched.

The one structured, merit-reviewed pathway accessible to outsiders is the Alliance for Therapies in Neuroscience (ATN), a decade-long partnership between the Weill Neurohub and Genentech/Roche providing up to $53M for neurological disease therapeutic research. Faculty at member institutions — UCSF, UC Berkeley, University of Washington, and the Allen Institute — can compete for ATN funding through periodic RFPs, including an active 2026 solicitation. This is the only publicly announced, eligibility-defined funding channel connected to Weill Family Foundation philanthropy.

Organizations outside the ATN ecosystem should realistically plan a 3–5 year relationship-building horizon before any meaningful engagement with the foundation, starting with collaborative research with hub faculty and publication in high-impact journals.

The Weill Family Foundation's grantmaking follows a sharply bimodal distribution. At the top end, three anchor institutional partnerships account for 83% of all recorded giving: UCSF Foundation received $24.9M across 9 grants, UC Berkeley Foundation received $10M across 2 grants, and Cornell University received $7.9M in a single transaction. Across 42 total recorded grants totaling $51.9M, the mathematical average is $1.24M — but this average is deeply misleading given the extreme concentration at the top.

The practical grant range runs from $5,000 (Center for Reproductive Rights) to $7.9M (Cornell University). The database-recorded median grant is $25,000, reflecting the foundation's pattern of making numerous small, personally motivated gifts — Hebrew Home for the Aged ($1M), Citymeals on Wheels ($480K), World Central Kitchen ($25K), Fair Girls Inc ($10K), Safehouse Denver ($10K) — alongside its transformational institutional commitments. By dollar weight, the top four grantees (UCSF, UC Berkeley, Cornell, University of Michigan at $3.9M) collectively represent roughly 90% of all recorded giving.

Annual giving has been highly volatile, tracking multi-year pledge distributions rather than a consistent payout rate: - 2019: $17.3M total giving / $16.6M grants paid - 2020: $9.5M / $9M - 2021: $7.9M / $6.7M (pandemic trough) - 2022: $18.8M / $18.1M - 2023: $20.9M / $19.6M - 2024: Grants paid data not yet filed; total assets grew to $390.2M on $49.9M revenue

This volatility is structural: when the Weills commit $50M or $100M to a named hub, payments flow as tranches over 3–10 years, creating large swings in any given year. The 2023 peak of $20.9M likely reflects accelerated distributions from the Neurohub pledge.

Geographically, New York captures 18 of 42 recorded grants, California 11, Washington D.C. 4, and Michigan 3. By dollar focus, neuroscience and neurological disease research accounts for roughly 75%+ of total dollar giving, with cancer research expanding rapidly as a second pillar through the 2025 hub announcements. Arts institutions represent approximately 6% and human services roughly 2% of cumulative giving.

The Weill Family Foundation occupies a distinctive niche among large private foundations funding neuroscience and medical research. Its closest peers by asset size and giving philosophy are foundations with similarly concentrated leadership, invited-only access, and a defining focus on translational brain science.

Among these, the Weill Foundation most closely resembles the Dana Foundation and Kavli Foundation in total asset scale ($200–400M), annual grantmaking ($15–25M), strictly non-solicited access, and a singular focus on neuroscience. Unlike the McKnight Foundation, which runs an open Neuroscience Research grants program with defined deadlines, neither the Weill nor Dana foundations publish open solicitations for general applicants.

What distinguishes the Weill Foundation from all peers is its hub-building strategy: concentrating $50M–$185M anchor gifts to create named institutional centers rather than distributing funds across many investigators. The Kavli Foundation uses a comparable institutional approach through its Kavli Institutes program. The Simons Foundation, though far larger, also favors long-term institutional commitments (the Simons Collaborations) that researchers join through invited nominations. For organizations seeking neuroscience funding through an open, merit-reviewed process, McKnight's competitive awards program remains the most accessible comparable option.

The Weill Family Foundation entered 2025 with its most ambitious philanthropic campaign in years, announcing two major cancer research initiatives in rapid succession. In March 2025, Sandy and Joan Weill announced a $50M gift establishing the Weill Cancer Hub East — a collaborative partnership among Princeton University, The Rockefeller University, Weill Cornell Medicine, and the Ludwig Institute for Cancer Research. The hub's research agenda focuses on how nutrition, metabolism, and the gut microbiome affect cancer immunotherapy effectiveness, with specific projects targeting GLP-1 agonists, tumor microenvironment reprogramming, and AI-assisted metabolomics. Sandy Weill stated publicly: "Joan and I could not be more excited about the endless possibilities of this special partnership — investment in science and medicine is our labor of love."

Two months later, in May 2025, the foundation announced a $100M matching grant for the Weill Cancer Hub West, uniting UCSF's Helen Diller Family Comprehensive Cancer Center and the Stanford Cancer Institute in a $200M, 10-year initiative. Partner institutions committed to raising $50M apiece in matching gifts. Together, the 2025 cancer hub announcements represent the largest strategic expansion since the $106M Weill Neurohub launch in November 2019.

On the neuroscience side, the Allen Institute for Brain Science joined the Weill Neurohub as its fourth institutional partner in March 2024. The ATN partnership with Genentech and Roche, established in 2021 with up to $53M in support across a decade, issued an active 2026 RFP for translational neuroscience research. Foundation assets grew to $390.2M in fiscal year 2024 (from $359.5M in 2023) on $49.9M in revenues, suggesting continued capacity for elevated grantmaking through 2026.

Because the Weill Family Foundation operates as a preselected-only grantmaker, conventional grant-writing strategies — cold LOIs, program officer outreach, foundation portal applications — are not applicable. The following guidance is specific to organizations pursuing a realistic pathway into the Weill ecosystem.

Pursue ATN eligibility as the primary near-term strategy. The Alliance for Therapies in Neuroscience is the only active, merit-reviewed competitive funding channel within the Weill ecosystem. A 2026 RFP is posted at weillneurohub.org. Eligibility is limited to faculty at member institutions (UCSF, UC Berkeley, University of Washington, Allen Institute). Researchers at non-hub institutions should pursue co-investigator roles with hub faculty or apply for joint appointments that confer eligibility.

Frame any major approach around the hub model, not project grants. The Weills do not fund individual investigators or one-cycle research projects through direct outreach. Organizations presenting major asks must articulate a named, multi-institution research collaboration addressing a frontier in neuroscience, neuropsychiatric disease, or cancer. The proposal architecture that resonates is: two or more anchor institutions + a defined 10-year research agenda + a named legacy opportunity for the Weills.

Align language with the Neurohub's four scientific pillars. Explicitly reference imaging, engineering, genomics and molecular therapeutics, and computation and data analytics. Proposals should emphasize translational potential — moving from bench to therapeutic application — as the ATN partnership with Genentech/Roche centers on drug development, not basic science alone.

Build credibility through existing grantee relationships. UCSF, Weill Cornell Medicine, the University of Michigan, and Carnegie Hall have the foundation's deepest sustained relationships. Introductions from institutional presidents, provosts, or board members at these organizations carry significantly more weight than any direct outreach.

For arts and human services organizations: Giving in this tier is almost entirely relationship-driven and personally solicited. Joan Weill is the primary arts philanthropist in the family; organizations with connections to the New York performing arts community — particularly those with existing Carnegie Hall or Alvin Ailey affiliations — are best positioned. Grant sizes in this tier range from $5K to $480K and recur annually for multi-year periods, suggesting the Weills make these commitments through personal relationships they maintain over decades.

Timing: Major institutional gifts are announced at naming-opportunity milestones — building campaigns, center launches, institutional anniversaries. Research hospitals and universities approaching the Weills should synchronize outreach with these institutional windows rather than the foundation's fiscal year calendar.